-
1
-
-
67649424560
-
p21 in cancer: intricate networks and multiple activities
-
Abbas, T., and A. Dutta. 2009. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer. 9:400-414. http://dx.doi.org/10.1038/nrc2657.
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 400-414
-
-
Abbas, T.1
Dutta, A.2
-
2
-
-
35548936833
-
Models, mechanisms and clinical evidence for cancer dormancy
-
Aguirre-Ghiso, J.A. 2007. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer. 7:834-846. http://dx.doi.org/10.1038/nrc2256.
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 834-846
-
-
Aguirre-Ghiso, J.A.1
-
3
-
-
0035172910
-
Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo
-
Aguirre-Ghiso, J.A., D. Liu, A. Mignatti, K. Kovalski, and L. Ossowski. 2001. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol. Biol. Cell. 12:863-879.
-
(2001)
Mol. Biol. Cell
, vol.12
, pp. 863-879
-
-
Aguirre-Ghiso, J.A.1
Liu, D.2
Mignatti, A.3
Kovalski, K.4
Ossowski, L.5
-
4
-
-
0037379794
-
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)
-
Aguirre-Ghiso, J.A., Y. Estrada, D. Liu, and L. Ossowski. 2003. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res. 63:1684-1695.
-
(2003)
Cancer Res
, vol.63
, pp. 1684-1695
-
-
Aguirre-Ghiso, J.A.1
Estrada, Y.2
Liu, D.3
Ossowski, L.4
-
5
-
-
5644222639
-
Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth
-
Aguirre-Ghiso, J.A., L. Ossowski, and S.K. Rosenbaum. 2004. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 64:7336-7345. http://dx.doi.org/10.1158/0008-5472.CAN-04-0113.
-
(2004)
Cancer Res
, vol.64
, pp. 7336-7345
-
-
Aguirre-Ghiso, J.A.1
Ossowski, L.2
Rosenbaum, S.K.3
-
6
-
-
33750480214
-
Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma
-
Ando, T., H. Ishiguro, M. Kimura, A. Mitsui, H. Kurehara, N. Sugito, K. Tomoda, R. Mori, N. Takashima, R. Ogawa, et al. 2006. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis. Esophagus. 19:454-458. http://dx.doi.org/10.1111/j.1442-2050.2006.00618.x.
-
(2006)
Dis. Esophagus
, vol.19
, pp. 454-458
-
-
Ando, T.1
Ishiguro, H.2
Kimura, M.3
Mitsui, A.4
Kurehara, H.5
Sugito, N.6
Tomoda, K.7
Mori, R.8
Takashima, N.9
Ogawa, R.10
-
7
-
-
45849087087
-
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence
-
Ansieau, S., J. Bastid, A. Doreau, A.-P. Morel, B.P. Bouchet, C. Thomas, F. Fauvet, I. Puisieux, C. Doglioni, S. Piccinin, et al. 2008. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 14:79-89. http://dx.doi.org/10.1016/j.ccr.2008.06.005.
-
(2008)
Cancer Cell
, vol.14
, pp. 79-89
-
-
Ansieau, S.1
Bastid, J.2
Doreau, A.3
Morel, A.-P.4
Bouchet, B.P.5
Thomas, C.6
Fauvet, F.7
Puisieux, I.8
Doglioni, C.9
Piccinin, S.10
-
8
-
-
61849129365
-
The M-type receptor PLA2R regulates senescence through the p53 pathway
-
Augert, A., C. Payré, Y. de Launoit, J. Gil, G. Lambeau, and D. Bernard. 2009. The M-type receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep. 10:271-277. http://dx.doi.org/10.1038/embor.2008.255.
-
(2009)
EMBO Rep
, vol.10
, pp. 271-277
-
-
Augert, A.1
Payré, C.2
de Launoit, Y.3
Gil, J.4
Lambeau, G.5
Bernard, D.6
-
9
-
-
0037447321
-
The Drg-1 gene suppresses tumor metastasis in prostate cancer
-
Bandyopadhyay, S., S.K. Pai, S.C. Gross, S. Hirota, S. Hosobe, K. Miura, K. Saito, T. Commes, S. Hayashi, M. Watabe, and K. Watabe. 2003. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 63:1731-1736.
-
(2003)
Cancer Res
, vol.63
, pp. 1731-1736
-
-
Bandyopadhyay, S.1
Pai, S.K.2
Gross, S.C.3
Hirota, S.4
Hosobe, S.5
Miura, K.6
Saito, K.7
Commes, T.8
Hayashi, S.9
Watabe, M.10
Watabe, K.11
-
10
-
-
3342962720
-
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression
-
Bandyopadhyay, S., S.K. Pai, S. Hirota, S. Hosobe, Y. Takano, K. Saito, D. Piquemal, T. Commes, M. Watabe, S.C. Gross, et al. 2004. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene. 23:5675-5681. http://dx.doi.org/10.1038/sj.onc.1207734.
-
(2004)
Oncogene
, vol.23
, pp. 5675-5681
-
-
Bandyopadhyay, S.1
Pai, S.K.2
Hirota, S.3
Hosobe, S.4
Takano, Y.5
Saito, K.6
Piquemal, D.7
Commes, T.8
Watabe, M.9
Gross, S.C.10
-
11
-
-
33846197078
-
The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer
-
Bandyopadhyay, S., Y. Wang, R. Zhan, S.K. Pai, M. Watabe, M. Iiizumi, E. Furuta, S. Mohinta, W. Liu, S. Hirota, et al. 2006. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res. 66:11983-11990. http://dx.doi.org/10.1158/0008-5472.CAN-06-0943.
-
(2006)
Cancer Res
, vol.66
, pp. 11983-11990
-
-
Bandyopadhyay, S.1
Wang, Y.2
Zhan, R.3
Pai, S.K.4
Watabe, M.5
Iiizumi, M.6
Furuta, E.7
Mohinta, S.8
Liu, W.9
Hirota, S.10
-
12
-
-
0041966056
-
Reversal of human cellular senescence: roles of the p53 and p16 pathways
-
Beauséjour, C.M., A. Krtolica, F. Galimi, M. Narita, S.W. Lowe, P. Yaswen, and J. Campisi. 2003. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22:4212-4222. http://dx.doi.org/10.1093/emboj/cdg417.
-
(2003)
EMBO J
, vol.22
, pp. 4212-4222
-
-
Beauséjour, C.M.1
Krtolica, A.2
Galimi, F.3
Narita, M.4
Lowe, S.W.5
Yaswen, P.6
Campisi, J.7
-
13
-
-
9244227134
-
Stromal fibroblasts in cancer initiation and progression
-
Bhowmick, N.A., E.G. Neilson, and H.L. Moses. 2004. Stromal fibroblasts in cancer initiation and progression. Nature. 432:332-337. http://dx.doi.org/10.1038/nature03096.
-
(2004)
Nature
, vol.432
, pp. 332-337
-
-
Bhowmick, N.A.1
Neilson, E.G.2
Moses, H.L.3
-
14
-
-
18844444202
-
Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer
-
Bobinac, D., I. Marić, S. Zoricić, J. Spanjol, G. Dordević, E. Mustać, and Z. Fuckar. 2005. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat. Med. J. 46:389-396.
-
(2005)
Croat. Med. J
, vol.46
, pp. 389-396
-
-
Bobinac, D.1
Marić, I.2
Zoricić, S.3
Spanjol, J.4
Dordević, G.5
Mustać, E.6
Fuckar, Z.7
-
15
-
-
34548804505
-
Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer
-
Buijs, J.T., N.V. Henriquez, P.G.M. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, P. Ten Dijke, A.-M. Cleton-Jansen, K. Driouch, et al. 2007. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res. 67:8742-8751. http://dx.doi.org/10.1158/0008-5472.CAN-06-2490.
-
(2007)
Cancer Res
, vol.67
, pp. 8742-8751
-
-
Buijs, J.T.1
Henriquez, N.V.2
van Overveld, P.G.M.3
van der Horst, G.4
Que, I.5
Schwaninger, R.6
Rentsch, C.7
Ten Dijke, P.8
Cleton-Jansen, A.-M.9
Driouch, K.10
-
16
-
-
7644223136
-
p38 MAP kinase"s emerging role as a tumor suppressor
-
G.F. Vande Woude, and G. Klein, editors. Elsevier Academic Press, San Diego.
-
Bulavin, D.V., and A.J. Fornace. 2004. p38 MAP kinase"s emerging role as a tumor suppressor. In Advances in Cancer Research, Vol. 92. G.F. Vande Woude, and G. Klein, editors. Elsevier Academic Press, San Diego. 95-118.
-
(2004)
Advances in Cancer Research
, vol.92
, pp. 95-118
-
-
Bulavin, D.V.1
Fornace, A.J.2
-
17
-
-
1842483852
-
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway
-
Bulavin, D.V., C. Phillips, B. Nannenga, O. Timofeev, L.A. Donehower, C.W. Anderson, E. Appella, and A.J. Fornace Jr. 2004. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36:343-350. http://dx.doi.org/10.1038/ng1317.
-
(2004)
Nat. Genet
, vol.36
, pp. 343-350
-
-
Bulavin, D.V.1
Phillips, C.2
Nannenga, B.3
Timofeev, O.4
Donehower, L.A.5
Anderson, C.W.6
Appella, E.7
Fornace Jr., A.J.8
-
18
-
-
0025672641
-
Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone
-
Celeste, A.J., J.A. Iannazzi, R.C. Taylor, R.M. Hewick, V. Rosen, E.A. Wang, and J.M. Wozney. 1990. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA. 87:9843-9847. http://dx.doi.org/10.1073/pnas.87.24.9843.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 9843-9847
-
-
Celeste, A.J.1
Iannazzi, J.A.2
Taylor, R.C.3
Hewick, R.M.4
Rosen, V.5
Wang, E.A.6
Wozney, J.M.7
-
19
-
-
12344291865
-
Bone morphogenetic proteins
-
Chen, D., M. Zhao, and G.R. Mundy. 2004. Bone morphogenetic proteins. Growth Factors. 22:233-241. http://dx.doi.org/10.1080/08977190412331279890.
-
(2004)
Growth Factors
, vol.22
, pp. 233-241
-
-
Chen, D.1
Zhao, M.2
Mundy, G.R.3
-
20
-
-
0036721051
-
Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival
-
Cheville, J.C., D. Tindall, C. Boelter, R. Jenkins, C.M. Lohse, V.S. Pankratz, T.J. Sebo, B. Davis, and M.L. Blute. 2002. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer. 95:1028-1036. http://dx.doi.org/10.1002/cncr.10788.
-
(2002)
Cancer
, vol.95
, pp. 1028-1036
-
-
Cheville, J.C.1
Tindall, D.2
Boelter, C.3
Jenkins, R.4
Lohse, C.M.5
Pankratz, V.S.6
Sebo, T.J.7
Davis, B.8
Blute, M.L.9
-
21
-
-
0037145687
-
Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1)
-
Chubinskaya, S., B. Kumar, C. Merrihew, K. Heretis, D.C. Rueger, and K.E. Kuettner. 2002. Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). Biochim. Biophys. Acta. 1588:126-134.
-
(2002)
Biochim. Biophys. Acta
, vol.1588
, pp. 126-134
-
-
Chubinskaya, S.1
Kumar, B.2
Merrihew, C.3
Heretis, K.4
Rueger, D.C.5
Kuettner, K.E.6
-
22
-
-
33845345975
-
Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements
-
Dasari, A., J.N. Bartholomew, D. Volonte, and F. Galbiati. 2006. Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res. 66:10805-10814. http://dx.doi.org/10.1158/0008-5472.CAN-06-1236.
-
(2006)
Cancer Res
, vol.66
, pp. 10805-10814
-
-
Dasari, A.1
Bartholomew, J.N.2
Volonte, D.3
Galbiati, F.4
-
23
-
-
0142104985
-
Smad-dependent and Smad-independent pathways in TGF-? family signalling
-
Derynck, R., and Y.E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-? family signalling. Nature. 425:577-584. http://dx.doi.org/10.1038/nature02006.
-
(2003)
Nature
, vol.425
, pp. 577-584
-
-
Derynck, R.1
Zhang, Y.E.2
-
24
-
-
0034785348
-
TGF-β signaling in tumor suppression and cancer progression
-
Derynck, R., R.J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29:117-129. http://dx.doi.org/10.1038/ng1001-117.
-
(2001)
Nat. Genet
, vol.29
, pp. 117-129
-
-
Derynck, R.1
Akhurst, R.J.2
Balmain, A.3
-
25
-
-
0037686707
-
Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53
-
Dirac, A.M.G., and R. Bernards. 2003. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278: 11731-11734. http://dx.doi.org/10.1074/jbc.C300023200.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 11731-11734
-
-
Dirac, A.M.G.1
Bernards, R.2
-
26
-
-
0028832707
-
A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye
-
Dudley, A.T., K.M. Lyons, and E.J. Robertson. 1995. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9:2795-2807. http://dx.doi.org/10.1101/gad.9.22.2795.
-
(1995)
Genes Dev
, vol.9
, pp. 2795-2807
-
-
Dudley, A.T.1
Lyons, K.M.2
Robertson, E.J.3
-
27
-
-
38849111785
-
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
-
Ellen, T.P., Q. Ke, P. Zhang, and M. Costa. 2008. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis. 29:2-8. http://dx.doi.org/10.1093/carcin/bgm200.
-
(2008)
Carcinogenesis
, vol.29
, pp. 2-8
-
-
Ellen, T.P.1
Ke, Q.2
Zhang, P.3
Costa, M.4
-
28
-
-
0035222452
-
Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions
-
Friedlaender, G.E., C.R. Perry, J.D. Cole, S.D. Cook, G. Cierny, G.F. Muschler, G.A. Zych, J.H. Calhoun, A.J. LaForte, and S. Yin. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 83-A:S151-S158.
-
(2001)
J. Bone Joint Surg. Am
, vol.83 A
-
-
Friedlaender, G.E.1
Perry, C.R.2
Cole, J.D.3
Cook, S.D.4
Cierny, G.5
Muschler, G.F.6
Zych, G.A.7
Calhoun, J.H.8
LaForte, A.J.9
Yin, S.10
-
29
-
-
2142717404
-
Gene expression profiling predicts clinical outcome of prostate cancer
-
Glinsky, G.V., A.B. Glinskii, A.J. Stephenson, R.M. Hoffman, and W.L. Gerald. 2004. Gene expression profiling predicts clinical outcome of prostate cancer. J. Clin. Invest. 113:913-923.
-
(2004)
J. Clin. Invest.
, vol.113
, pp. 913-923
-
-
Glinsky, G.V.1
Glinskii, A.B.2
Stephenson, A.J.3
Hoffman, R.M.4
Gerald, W.L.5
-
30
-
-
0033972140
-
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer
-
Guan, R.J., H.L. Ford, Y. Fu, Y. Li, L.M. Shaw, and A.B. Pardee. 2000. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 60:749-755.
-
(2000)
Cancer Res.
, vol.60
, pp. 749-755
-
-
Guan, R.J.1
Ford, H.L.2
Fu, Y.3
Li, Y.4
Shaw, L.M.5
Pardee, A.B.6
-
31
-
-
33750738067
-
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
-
Guise, T.A., K.S. Mohammad, G. Clines, E.G. Stebbins, D.H. Wong, L.S. Higgins, R. Vessella, E. Corey, S. Padalecki, L. Suva, and J.M. Chirgwin. 2006. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin. Cancer Res. 12:6213s-6216s. http://dx.doi.org/10.1158/1078-0432.CCR-06-1007.
-
(2006)
Clin. Cancer Res
, vol.12
-
-
Guise, T.A.1
Mohammad, K.S.2
Clines, G.3
Stebbins, E.G.4
Wong, D.H.5
Higgins, L.S.6
Vessella, R.7
Corey, E.8
Padalecki, S.9
Suva, L.10
Chirgwin, J.M.11
-
32
-
-
34547212349
-
The pathways to tumor suppression via route p38
-
Han, J., and P. Sun. 2007. The pathways to tumor suppression via route p38. Trends Biochem. Sci. 32:364-371. http://dx.doi.org/10.1016/j.tibs .2007.06.007.
-
(2007)
Trends Biochem. Sci.
, vol.32
, pp. 364-371
-
-
Han, J.1
Sun, P.2
-
33
-
-
33644502513
-
The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma
-
Hickson, J.A., D. Huo, D.J. Vander Griend, A. Lin, C.W. Rinker-Schaeffer, and S.D. Yamada. 2006. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res. 66:2264-2270. http://dx.doi.org/10.1158/0008-5472. CAN-05-3676.
-
(2006)
Cancer Res.
, vol.66
, pp. 2264-2270
-
-
Hickson, J.A.1
Huo, D.2
Vander Griend, D.J.3
Lin, A.4
Rinker-Schaeffer, C.W.5
Yamada, S.D.6
-
34
-
-
0033590636
-
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
-
Hoshino, R., Y. Chatani, T. Yamori, T. Tsuruo, H. Oka, O. Yoshida, Y. Shimada, S. Ari-i, H. Wada, J. Fujimoto, and M. Kohno. 1999. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene. 18:813-822. http://dx.doi.org/10.1038/sj.onc.1202367.
-
(1999)
Oncogene
, vol.18
, pp. 813-822
-
-
Hoshino, R.1
Chatani, Y.2
Yamori, T.3
Tsuruo, T.4
Oka, H.5
Yoshida, O.6
Shimada, Y.7
Ari-i, S.8
Wada, H.9
Fujimoto, J.10
Kohno, M.11
-
35
-
-
22744434737
-
Bone morphogenetic proteins in vascular calcification
-
Hruska, K.A., S. Mathew, and G. Saab. 2005. Bone morphogenetic proteins in vascular calcification. Circ. Res. 97:105-114. http://dx.doi.org/10.1161/01.RES.00000175571.53833.6c.
-
(2005)
Circ. Res
, vol.97
, pp. 105-114
-
-
Hruska, K.A.1
Mathew, S.2
Saab, G.3
-
36
-
-
0032554765
-
FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells
-
Johnson, M.R., C. Valentine, C. Basilico, and A. Mansukhani. 1998. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Oncogene. 16:2647-2656. http://dx.doi.org/10.1038/sj.onc.1201789.
-
(1998)
Oncogene
, vol.16
, pp. 2647-2656
-
-
Johnson, M.R.1
Valentine, C.2
Basilico, C.3
Mansukhani, A.4
-
37
-
-
0033528092
-
Dormancy of mammary carcinoma after mastectomy
-
Karrison, T.G., D.J. Ferguson, and P. Meier. 1999. Dormancy of mammary carcinoma after mastectomy. J. Natl. Cancer Inst. 91:80-85. http://dx.doi.org/10.1093/jnci/91.1.80.
-
(1999)
J. Natl. Cancer Inst
, vol.91
, pp. 80-85
-
-
Karrison, T.G.1
Ferguson, D.J.2
Meier, P.3
-
38
-
-
5644221401
-
Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1
-
Kim, I.Y., D.-H. Lee, D.K. Lee, W.J. Kim, M.M. Kim, R.A. Morton, S.P. Lerner, and S.J. Kim. 2004. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1. Cancer Res. 64:7355-7360. http://dx.doi.org/10.1158/0008-5472.CAN-04-0154.
-
(2004)
Cancer Res.
, vol.64
, pp. 7355-7360
-
-
Kim, I.Y.1
Lee, D.-H.2
Lee, D.K.3
Kim, W.J.4
Kim, M.M.5
Morton, R.A.6
Lerner, S.P.7
Kim, S.J.8
-
39
-
-
0034616116
-
Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription
-
Kitaura, H., M. Shinshi, Y. Uchikoshi, T. Ono, S.M. Iguchi-Ariga, and H. Ariga. 2000. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J. Biol. Chem. 275:10477-10483. http://dx.doi .org/10.1074/jbc.275.14.10477.
-
(2000)
J. Biol. Chem
, vol.275
, pp. 10477-10483
-
-
Kitaura, H.1
Shinshi, M.2
Uchikoshi, Y.3
Ono, T.4
Iguchi-Ariga, S.M.5
Ariga, H.6
-
40
-
-
38049029612
-
The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer
-
Kodach, L.L., S.A. Bleuming, A.R. Musler, M.P. Peppelenbosch, D.W. Hommes, G.R. van den Brink, C.J.M. van Noesel, G.J.A. Offerhaus, and J.C.H. Hardwick. 2008a. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer. 112:300-306. http://dx.doi.org/10.1002/cncr.23160.
-
(2008)
Cancer
, vol.112
, pp. 300-306
-
-
Kodach, L.L.1
Bleuming, S.A.2
Musler, A.R.3
Peppelenbosch, M.P.4
Hommes, D.W.5
van den Brink, G.R.6
van Noesel, C.J.M.7
Offerhaus, G.J.A.8
Hardwick, J.C.H.9
-
41
-
-
42949160593
-
The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers
-
Kodach, L.L., E. Wiercinska, N.F.C.C. de Miranda, S.A. Bleuming, A.R. Musler, M.P. Peppelenbosch, E. Dekker, G.R. van den Brink, C.J.M. van Noesel, H. Morreau, et al. 2008b. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenterology. 134:1332-1341. http://dx.doi.org/10.1053/j.gastro.2008.02.059.
-
(2008)
Gastroenterology
, vol.134
, pp. 1332-1341
-
-
Kodach, L.L.1
Wiercinska, E.2
de Miranda, N.F.C.C.3
Bleuming, S.A.4
Musler, A.R.5
Peppelenbosch, M.P.6
Dekker, E.7
van den Brink, G.R.8
van Noesel, C.J.M.9
Morreau, H.10
-
42
-
-
3042819503
-
Integrin α5β1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow
-
Korah, R., M. Boots, and R. Wieder. 2004. Integrin α5β1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Cancer Res. 64:4514-4522. http://dx.doi.org/10.1158/0008-5472.CAN-03-3853.
-
(2004)
Cancer Res
, vol.64
, pp. 4514-4522
-
-
Korah, R.1
Boots, M.2
Wieder, R.3
-
43
-
-
0041884865
-
The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N-or c-myc
-
Li, J., and L. Kretzner. 2003. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N-or c-myc. Mol. Cell. Biochem. 250:91-105. http://dx.doi.org/10.1023/A:1024918328162.
-
(2003)
Mol. Cell. Biochem
, vol.250
, pp. 91-105
-
-
Li, J.1
Kretzner, L.2
-
44
-
-
41649109459
-
Zeb1 links epithelial-mesenchymal transition and cellular senescence
-
Liu, Y., S. El-Naggar, D.S. Darling, Y. Higashi, and D.C. Dean. 2008. Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development. 135:579-588. http://dx.doi.org/10.1242/dev.007047.
-
(2008)
Development
, vol.135
, pp. 579-588
-
-
Liu, Y.1
El-Naggar, S.2
Darling, D.S.3
Higashi, Y.4
Dean, D.C.5
-
45
-
-
0028882261
-
BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning
-
Luo, G., C. Hofmann, A.L. Bronckers, M. Sohocki, A. Bradley, and G. Karsenty. 1995. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:2808-2820. http://dx.doi.org/10.1101/gad.9.22.2808.
-
(1995)
Genes Dev
, vol.9
, pp. 2808-2820
-
-
Luo, G.1
Hofmann, C.2
Bronckers, A.L.3
Sohocki, M.4
Bradley, A.5
Karsenty, G.6
-
46
-
-
33745700194
-
Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis
-
Maruyama, Y., M. Ono, A. Kawahara, T. Yokoyama, Y. Basaki, M. Kage, S. Aoyagi, H. Kinoshita, and M. Kuwano. 2006. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res. 66:6233-6242. http://dx.doi.org/10.1158/0008-5472.CAN-06-0183.
-
(2006)
Cancer Res
, vol.66
, pp. 6233-6242
-
-
Maruyama, Y.1
Ono, M.2
Kawahara, A.3
Yokoyama, T.4
Basaki, Y.5
Kage, M.6
Aoyagi, S.7
Kinoshita, H.8
Kuwano, M.9
-
47
-
-
47549090432
-
TGFbeta in Cancer
-
Massagué, J. 2008. TGFbeta in Cancer. Cell. 134:215-230. http://dx.doi .org/10.1016/j.cell.2008.07.001.
-
(2008)
Cell
, vol.134
, pp. 215-230
-
-
Massagué, J.1
-
48
-
-
44649088833
-
Systemic endocrine instigation of indolent tumor growth requires osteopontin
-
McAllister, S.S., A.M. Gifford, A.L. Greiner, S.P. Kelleher, M.P. Saelzler, T.A. Ince, F. Reinhardt, L.N. Harris, B.L. Hylander, E.A. Repasky, and R.A. Weinberg. 2008. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell. 133:994-1005. http://dx.doi .org/10.1016/j.cell.2008.04.045.
-
(2008)
Cell
, vol.133
, pp. 994-1005
-
-
McAllister, S.S.1
Gifford, A.M.2
Greiner, A.L.3
Kelleher, S.P.4
Saelzler, M.P.5
Ince, T.A.6
Reinhardt, F.7
Harris, L.N.8
Hylander, B.L.9
Repasky, E.A.10
Weinberg, R.A.11
-
49
-
-
0030792319
-
Bone morphogenetic proteins in the nervous system
-
Mehler, M.F., P.C. Mabie, D. Zhang, and J.A. Kessler. 1997. Bone morphogenetic proteins in the nervous system. Trends Neurosci. 20:309-317. http://dx.doi.org/10.1016/S0166-2236(96)01046-6.
-
(1997)
Trends Neurosci
, vol.20
, pp. 309-317
-
-
Mehler, M.F.1
Mabie, P.C.2
Zhang, D.3
Kessler, J.A.4
-
50
-
-
75649127963
-
Bone morphogenetic protein receptors and signal transduction
-
Miyazono, K., Y. Kamiya, and M. Morikawa. 2010. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147:35-51. http://dx.doi.org/10.1093/jb/mvp148.
-
(2010)
J. Biochem
, vol.147
, pp. 35-51
-
-
Miyazono, K.1
Kamiya, Y.2
Morikawa, M.3
-
51
-
-
76749108468
-
Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment
-
Morrissey, C., L.G. Brown, T.E. Pitts, R.L. Vessella, and E. Corey. 2010. Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment. Neoplasia. 12:192-205.
-
(2010)
Neoplasia
, vol.12
, pp. 192-205
-
-
Morrissey, C.1
Brown, L.G.2
Pitts, T.E.3
Vessella, R.L.4
Corey, E.5
-
52
-
-
0036675220
-
Metastasis to bone: causes, consequences and therapeutic opportunities
-
Mundy, G.R. 2002. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer. 2:584-593. http://dx.doi.org/10.1038/nrc867.
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 584-593
-
-
Mundy, G.R.1
-
53
-
-
84948011740
-
Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer
-
Niell, H.B., G.M. Palmieri, C.L. Neely, T.A. Maxwell, S.C. Hopkins, and M.S. Soloway. 1983. Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer. Arch. Intern. Med. 143:1925-1927. http://dx.doi.org/10.1001/archinte.143.10.1925.
-
(1983)
Arch. Intern. Med
, vol.143
, pp. 1925-1927
-
-
Niell, H.B.1
Palmieri, G.M.2
Neely, C.L.3
Maxwell, T.A.4
Hopkins, S.C.5
Soloway, M.S.6
-
54
-
-
0025362715
-
OP-1 cDNA encodes an osteogenic protein in the TGF-beta family
-
Ozkaynak, E., D.C. Rueger, E.A. Drier, C. Corbett, R.J. Ridge, T.K. Sampath, and H. Oppermann. 1990. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 9:2085-2093.
-
(1990)
EMBO J
, vol.9
, pp. 2085-2093
-
-
Ozkaynak, E.1
Rueger, D.C.2
Drier, E.A.3
Corbett, C.4
Ridge, R.J.5
Sampath, T.K.6
Oppermann, H.7
-
55
-
-
33846698253
-
The clinical significance of circulating tumor cells
-
Pantel, K., and C. Alix-Panabières. 2007. The clinical significance of circulating tumor cells. Nat. Clin. Pract. Oncol. 4:62-63. http://dx.doi.org/10.1038/ncponc0737.
-
(2007)
Nat. Clin. Pract. Oncol
, vol.4
, pp. 62-63
-
-
Pantel, K.1
Alix-Panabières, C.2
-
56
-
-
54549087727
-
Inflammation joins the "niche"
-
Peinado, H., S. Rafii, and D. Lyden. 2008. Inflammation joins the "niche". Cancer Cell. 14:347-349. http://dx.doi.org/10.1016/j.ccr.2008.10.012.
-
(2008)
Cancer Cell
, vol.14
, pp. 347-349
-
-
Peinado, H.1
Rafii, S.2
Lyden, D.3
-
57
-
-
33745184002
-
Telomerase activity in disseminated prostate cancer cells
-
Pfitzenmaier, J., W.J. Ellis, E.W. Arfman, S. Hawley, P.O. McLaughlin, P.H. Lange, and R.L. Vessella. 2006. Telomerase activity in disseminated prostate cancer cells. BJU Int. 97:1309-1313. http://dx.doi.org/10.1111/j.1464-410X.2006.06194.x.
-
(2006)
BJU Int
, vol.97
, pp. 1309-1313
-
-
Pfitzenmaier, J.1
Ellis, W.J.2
Arfman, E.W.3
Hawley, S.4
McLaughlin, P.O.5
Lange, P.H.6
Vessella, R.L.7
-
58
-
-
63049123066
-
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
-
Polyak, K., and R.A. Weinberg. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer. 9:265-273. http://dx.doi.org/10.1038/nrc2620.
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 265-273
-
-
Polyak, K.1
Weinberg, R.A.2
-
59
-
-
0029911896
-
Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7)
-
Ripamonti, U., B. Van Den Heever, T.K. Sampath, M.M. Tucker, D.C. Rueger, and A.H. Reddi. 1996. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors. 13:273-289. http://dx.doi.org/10.3109/08977199609003228.
-
(1996)
Growth Factors
, vol.13
, pp. 273-289
-
-
Ripamonti, U.1
Van Den Heever, B.2
Sampath, T.K.3
Tucker, M.M.4
Rueger, D.C.5
Reddi, A.H.6
-
60
-
-
33947229511
-
RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation
-
Ristiniemi, J., T. Flinkkilä, P. Hyvönen, M. Lakovaara, H. Pakarinen, and P. Jalovaara. 2007. RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. J. Bone Joint Surg. Br. 89-B:265-272. http://dx.doi.org/10.1302/0301-620X.89B2.18230.
-
(2007)
J. Bone Joint Surg. Br
, vol.89 B
, pp. 265-272
-
-
Ristiniemi, J.1
Flinkkilä, T.2
Hyvönen, P.3
Lakovaara, M.4
Pakarinen, H.5
Jalovaara, P.6
-
61
-
-
67649939163
-
The increasing complexity of the cancer stem cell paradigm
-
Rosen, J.M., and C.T. Jordan. 2009. The increasing complexity of the cancer stem cell paradigm. Science. 324:1670-1673. http://dx.doi.org/10.1126/science.1171837.
-
(2009)
Science
, vol.324
, pp. 1670-1673
-
-
Rosen, J.M.1
Jordan, C.T.2
-
62
-
-
0038342441
-
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
-
Sage, J., A.L. Miller, P.A. Pérez-Mancera, J.M. Wysocki, and T. Jacks. 2003. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature. 424:223-228. http://dx.doi.org/10.1038/nature01764.
-
(2003)
Nature
, vol.424
, pp. 223-228
-
-
Sage, J.1
Miller, A.L.2
Pérez-Mancera, P.A.3
Wysocki, J.M.4
Jacks, T.5
-
63
-
-
0026739256
-
Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro
-
Sampath, T.K., J.C. Maliakal, P.V. Hauschka, W.K. Jones, H. Sasak, R.F. Tucker, K.H. White, J.E. Coughlin, M.M. Tucker, R.H. Pang, et al. 1992. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:20352-20362.
-
(1992)
J. Biol. Chem
, vol.267
, pp. 20352-20362
-
-
Sampath, T.K.1
Maliakal, J.C.2
Hauschka, P.V.3
Jones, W.K.4
Sasak, H.5
Tucker, R.F.6
White, K.H.7
Coughlin, J.E.8
Tucker, M.M.9
Pang, R.H.10
-
64
-
-
0027085874
-
Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray
-
Shimazaki, J., T. Higa, S. Akimoto, M. Masai, and S. Isaka. 1992. Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray. Adv. Exp. Med. Biol. 324:269-275. http://dx.doi.org/10.1007/978-1-4615-3398-6_29.
-
(1992)
Adv. Exp. Med. Biol
, vol.324
, pp. 269-275
-
-
Shimazaki, J.1
Higa, T.2
Akimoto, S.3
Masai, M.4
Isaka, S.5
-
65
-
-
0035960116
-
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer
-
Smith, M.R., F.J. McGovern, A.L. Zietman, M.A. Fallon, D.L. Hayden, D.A. Schoenfeld, P.W. Kantoff, and J.S. Finkelstein. 2001. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N. Engl. J. Med. 345:948-955. http://dx.doi .org/10.1056/NEJMoa010845.
-
(2001)
N. Engl. J. Med
, vol.345
, pp. 948-955
-
-
Smith, M.R.1
McGovern, F.J.2
Zietman, A.L.3
Fallon, M.A.4
Hayden, D.L.5
Schoenfeld, D.A.6
Kantoff, P.W.7
Finkelstein, J.S.8
-
66
-
-
32944481493
-
Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer
-
Smith, M.R., W.C. Lee, J. Brandman, Q. Wang, M. Botteman, and C.L. Pashos. 2005. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J. Clin. Oncol. 23:7897-7903. http://dx.doi.org/10.1200/JCO .2004.00.6908.
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 7897-7903
-
-
Smith, M.R.1
Lee, W.C.2
Brandman, J.3
Wang, Q.4
Botteman, M.5
Pashos, C.L.6
-
67
-
-
41849150003
-
Metastasis: a therapeutic target for cancer
-
Steeg, P.S., and D. Theodorescu. 2008. Metastasis: a therapeutic target for cancer. Nat. Clin. Pract. Oncol. 5:206-219. http://dx.doi.org/10.1038/ncponc1066.
-
(2008)
Nat. Clin. Pract. Oncol
, vol.5
, pp. 206-219
-
-
Steeg, P.S.1
Theodorescu, D.2
-
68
-
-
33846282393
-
PRAK is essential for rasinduced senescence and tumor suppression
-
Sun, P., N. Yoshizuka, L. New, B.A. Moser, Y. Li, R. Liao, C. Xie, J. Chen, Q. Deng, M. Yamout, et al. 2007. PRAK is essential for rasinduced senescence and tumor suppression. Cell. 128:295-308. http://dx.doi.org/10.1016/j.cell.2006.11.050.
-
(2007)
Cell
, vol.128
, pp. 295-308
-
-
Sun, P.1
Yoshizuka, N.2
New, L.3
Moser, B.A.4
Li, Y.5
Liao, R.6
Xie, C.7
Chen, J.8
Deng, Q.9
Yamout, M.10
-
69
-
-
0031757317
-
Androgendependent gene expression of bone morphogenetic protein 7 in mouse prostate
-
Thomas, R., W.A. Anderson, V. Raman, and A.H. Reddi. 1998. Androgendependent gene expression of bone morphogenetic protein 7 in mouse prostate. Prostate. 37:236-245. http://dx.doi.org/10.1002/(SICI)1097-0045(19981201)37:4<236::AID-PROS5<;3.0.CO;2-C.
-
(1998)
Prostate
, vol.37
, pp. 236-245
-
-
Thomas, R.1
Anderson, W.A.2
Raman, V.3
Reddi, A.H.4
-
70
-
-
33749023927
-
Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence
-
Tront, J.S., B. Hoffman, and D.A. Liebermann. 2006. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res. 66:8448-8454. http://dx.doi.org/10.1158/0008-5472 .CAN-06-2013.
-
(2006)
Cancer Res
, vol.66
, pp. 8448-8454
-
-
Tront, J.S.1
Hoffman, B.2
Liebermann, D.A.3
-
71
-
-
0030799666
-
A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms
-
van Belzen, N., W.N. Dinjens, M.P. Diesveld, N.A. Groen, A.C. van der Made, Y. Nozawa, R. Vlietstra, J. Trapman, and F.T. Bosman. 1997. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab. Invest. 77:85-92.
-
(1997)
Lab. Invest
, vol.77
, pp. 85-92
-
-
van Belzen, N.1
Dinjens, W.N.2
Diesveld, M.P.3
Groen, N.A.4
van der Made, A.C.5
Nozawa, Y.6
Vlietstra, R.7
Trapman, J.8
Bosman, F.T.9
-
72
-
-
34249807348
-
p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
-
Ventura, J.J., S. Tenbaum, E. Perdiguero, M. Huth, C. Guerra, M. Barbacid, M. Pasparakis, and A.R. Nebreda. 2007. p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39:750-758. http://dx.doi.org/10.1038/ng2037.
-
(2007)
Nat. Genet
, vol.39
, pp. 750-758
-
-
Ventura, J.J.1
Tenbaum, S.2
Perdiguero, E.3
Huth, M.4
Guerra, C.5
Barbacid, M.6
Pasparakis, M.7
Nebreda, A.R.8
-
73
-
-
52549087785
-
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
-
Visvader, J.E., and G.J. Lindeman. 2008. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer. 8:755-768. http://dx.doi.org/10.1038/nrc2499.
-
(2008)
Nat. Rev. Cancer.
, vol.8
, pp. 755-768
-
-
Visvader, J.E.1
Lindeman, G.J.2
-
74
-
-
67749117934
-
Signal integration by JNK and p38 MAPK pathways in cancer development
-
Wagner, E.F., and A.R. Nebreda. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer. 9:537-549. http://dx.doi.org/10.1038/nrc2694.
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 537-549
-
-
Wagner, E.F.1
Nebreda, A.R.2
-
75
-
-
0034947347
-
Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value
-
Weckermann, D., P. Müller, F. Wawroschek, R. Harzmann, G. Riethmüller, and G. Schlimok. 2001. Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value. J. Urol. 166:699-703. http://dx.doi.org/10.1016/S0022-5347(05)66046-6.
-
(2001)
J. Urol
, vol.166
, pp. 699-703
-
-
Weckermann, D.1
Müller, P.2
Wawroschek, F.3
Harzmann, R.4
Riethmüller, G.5
Schlimok, G.6
-
76
-
-
59449092185
-
Single-vector inducible lentiviral RNAi system for oncology target validation
-
Wiederschain, D., S. Wee, L. Chen, A. Loo, G. Yang, A. Huang, Y. Chen, G. Caponigro, Y.M. Yao, C. Lengauer, et al. 2009. Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle. 8:498-504. http://dx.doi.org/10.4161/cc.8.3.7701.
-
(2009)
Cell Cycle
, vol.8
, pp. 498-504
-
-
Wiederschain, D.1
Wee, S.2
Chen, L.3
Loo, A.4
Yang, G.5
Huang, A.6
Chen, Y.7
Caponigro, G.8
Yao, Y.M.9
Lengauer, C.10
-
77
-
-
34547657084
-
Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists
-
Ye, L., J.M. Lewis-Russell, H. Kynaston, and W.G. Jiang. 2007. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. J. Urol. 178:1086-1091. http://dx.doi.org/10.1016/j.juro.2007.05.003.
-
(2007)
J. Urol
, vol.178
, pp. 1086-1091
-
-
Ye, L.1
Lewis-Russell, J.M.2
Kynaston, H.3
Jiang, W.G.4
-
78
-
-
0038717407
-
BMP-7 counteracts TGF-?1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
-
Zeisberg, M., J.-i. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz, and R. Kalluri. 2003. BMP-7 counteracts TGF-?1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9:964-968. http://dx.doi.org/10.1038/nm888.
-
(2003)
Nat. Med
, vol.9
, pp. 964-968
-
-
Zeisberg, M.1
Hanai, J.-I.2
Sugimoto, H.3
Mammoto, T.4
Charytan, D.5
Strutz, F.6
Kalluri, R.7
-
79
-
-
67649311599
-
Latent bone metastasis in breast cancer tied to Src-dependent survival signals
-
Zhang, X.H.F., Q. Wang, W. Gerald, C.A. Hudis, L. Norton, M. Smid, J.A. Foekens, and J. Massagué. 2009. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell. 16:67-78. http://dx.doi.org/10.1016/j.ccr.2009.05.017.
-
(2009)
Cancer Cell
, vol.16
, pp. 67-78
-
-
Zhang, X.H.F.1
Wang, Q.2
Gerald, W.3
Hudis, C.A.4
Norton, L.5
Smid, M.6
Foekens, J.A.7
Massagué, J.8
|